RxDoctor Payments Data

Timothy Burnett, DO

Family Medicine · Springfield, MONPI 1477817377

Payments from drug & device makers

$763in general payments, 2019–2025

Across 43 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$182
  • AstraZeneca$102
  • Exact Sciences$67
  • Novo Nordisk$65
  • Abbott$62
  • AbbVie$60
  • plus $225 from 9 others

What the payments were for

  • Food & beverage$763100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$763 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$73,950
Medicare patients
189
Services billed
1,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban162$141,625
OzempicSemaglutide96$115,958
JardianceEmpagliflozin57$66,977
MounjaroTirzepatide37$42,174
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$39,348
JanuviaSitagliptin Phosphate34$28,594
FarxigaDapagliflozin Propanediol21$20,085
TrulicityDulaglutide12$16,771
XareltoRivaroxaban13$15,816
SymbicortBudesonide/Formoterol Fumarate27$10,430
CreonLipase/Protease/Amylase16$10,237
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$9,767
ArexvyRsvpref3 Antigen/As01e/Pf35$8,793
MyrbetriqMirabegron11$8,732
Humalog Kwikpen U-100Insulin Lispro11$4,543

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$182$141,625162 claims
Novo NordiskOzempic$65$115,95896 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta$15$52,56298 claims
AstraZenecaFarxiga, Symbicort$102$30,51448 claims
AbbVieCreon, Synthroid$60$13,01855 claims
Astellas Pharma US IncMyrbetriq$23$8,73211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →